Caixin
Nov 09, 2023 05:04 PM
FINANCE

China Health Care Stocks on Road to Recovery After $142 Billion Rout

00:00
00:00/00:00
Listen to this article 1x
Strong earnings and cheap valuations have helped rekindle enthusiasm for health care stocks amid a background of an aging population and expanding middle class. Photo: Bloomberg
Strong earnings and cheap valuations have helped rekindle enthusiasm for health care stocks amid a background of an aging population and expanding middle class. Photo: Bloomberg

(Bloomberg) — Chinese health care stocks are back in vogue after a $142 billion wipeout, as signs grow that the worst of a government crackdown is over.

The Hang Seng Composite Healthcare Index, dominated by Chinese companies, has rallied 14% in the past month, having plunged 37% from a January peak after Beijing launched an anti-graft clampdown on the pharmaceutical sector.

loadingImg
You've accessed an article available only to subscribers
VIEW OPTIONS
Share this article
Open WeChat and scan the QR code
NEWSLETTERS
Get our CX Daily, weekly Must-Read and China Green Bulletin newsletters delivered free to your inbox, bringing you China's top headlines.

We ‘ve added you to our subscriber list.

Manage subscription
PODCAST